Clinical Trial Update: Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System [Phase 2]

View source ↗

Summary

Phase 2 safety extension study evaluating the biodegradation of the intravitreal Brimonidine tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)
• Brimo PS DDS

Snippet

Sponsor: Allergan | Conditions: Patients Who Participated in an Intravitreal Brimo PS DDS® Study | Phase 2 | Status: COMPLETED | Results posted: 2015-02-20